Erik Espling
- Oncology top 10%
- CAR-T cell therapy research 2
- Cancer-related Molecular Pathways 2
- Epidemiology top 10%
-
- Virus-based gene therapy research 1
-
- Monoclonal and Polyclonal Antibodies Research 3
-
- Lymphoma Diagnosis and Treatment 2
-
- Adenosine and Purinergic Signaling 1
-
- RNA modifications and cancer 1
- DNA Repair Mechanisms 1
- Co-authors
- Jo Beth HarryDenise A. GallowayJens Oliver FunkBruce StillmanS WagaBeth G. EtscheidG W DemersPhilip Tan
- Cited by
- OncologyEpidemiologyImmunology
- Partner nations
- United States
In The Last Decade
Erik Espling
6 papers receiving 540 citations
Peers
Comparison fields: 5 of 57
- Oncology 319
- Epidemiology 284
- Immunology 86
- Cancer Research 61
- Genetics 101
Countries citing papers authored by Erik Espling
This map shows the geographic impact of Erik Espling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Espling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Espling more than expected).
Fields of papers citing papers by Erik Espling
This network shows the impact of papers produced by Erik Espling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Espling. The network helps show where Erik Espling may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Erik Espling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 0 | |
| 2 | 2009 | 27 | |
| 3 | 2007 | 1 | |
| 4 | 2004 | 4 | |
| 5 | 2001 | 11 | |
| 6 | 1997 | 403 | |
| 7 | 1996 | 107 |
About Erik Espling
Erik Espling is a scholar working on Physiology, Immunology and Allergy and Oncology, having authored 7 papers that have together received 553 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (3 papers), CAR-T cell therapy research (2 papers), Cancer-related Molecular Pathways (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Adenosine and Purinergic Signaling (1 paper), RNA modifications and cancer (1 paper), Virus-based gene therapy research (1 paper) and DNA Repair Mechanisms (1 paper). The work is most often cited by research in Oncology (319 citations), Epidemiology (284 citations) and Immunology (86 citations). Erik Espling has collaborated with scholars based in United States. Frequent co-authors include Jo Beth Harry, Denise A. Galloway, Jens Oliver Funk, Bruce Stillman, S Waga, Beth G. Etscheid, G W Demers, Philip Tan, D. Barone and Peter A. Thompson. Their work appears in journals such as Genes & Development, Clinical Cancer Research, Endocrinology, Journal of Clinical Oncology and Cancer Immunology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.